Dezhan Healthcare Company Limited (SHE:000813)
China · Delayed Price · Currency is CNY 4.070
-0.050 (-1.21%)
Feb 3, 2026, 3:04 PM CST
Dezhan Healthcare Company Company Description
Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People’s Republic of China.
The company offers atorvastatin calcium tablets, amlodipine atorvastatin calcium tablets, trimetazidine hydrochloride capsules, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathioprine tablets, and hydroxyurea tablets and colchicine tablet.
It also involved in the provision of biological peptides, industrial hemp, and medical service business.
The company was founded in 1980 and is based in Beijing, the People’s Republic of China.
Dezhan Healthcare Company Limited
| Country | China |
| Founded | 1980 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,054 |
| CEO | Wei Liu |
Contact Details
Address: Bona Building Beijing, 100027 China | |
| Phone | 86 10 6585 8557 |
| Website | dezhanhealthcare.com |
Stock Details
| Ticker Symbol | 000813 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000000VV8 |
| SIC Code | 2200 |
Key Executives
| Name | Position |
|---|---|
| Zheming Wei | Chairman and Acting Secretary |
| Wei Liu | Co-Chairman and GM |
| Jinghong Zhang | Executive Vice President and Chief Financial Officer |
| Lang Chen | Accounting Supervisor |
| Ye Liu | Chief Scientist |
| Shubin Wang | Deputy General Manager |